| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 39819-27-7 | 2-((4-苯基哌嗪-1-基)甲基)喹啉 | 2-((4-Phenylpiperazine-1-yl)methyl)quinoline; 2-(4-Phenyl-1-piperazinyl)methylquinoline |  | C20H21N3 | 詳情 | 供應商 |
| 170105-16-5 | 咪達那新; 4-(2-甲基-1H-咪唑-1-基)-2,2-二苯基丁酰胺 | Imidafenacin; 4-(2-Methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide |  | C20H21N3O | 詳情 | 供應商 |
| 757942-43-1 | 貝得羅星; N-[4-溴-5-(1-氟乙烯基)-3-甲基噻吩-2-基甲基]-N'-(4-氧代-1,4-二氫喹啉-2-基)丙烷-1,3-二胺 | Bederocin; N-[4-Bromo-5-(1-fluorovinyl)-3-methylthiophen-2-ylmethyl]-N'-(4-oxo-1,4-dihydroquinolin-2-yl)propane-1,3-diamine |  | C20H21BrFN3OS | 詳情 | 供應商 |
| 76-82-4 | 肌氨酸酐 | Benzenemethanol,4-amino-a,a-bis(4-aminophenyl)-3-methyl-; Methanol,bis(p-aminophenyl)(4-amino-m-tolyl)- (7CI,8CI); C.I. Basic Violet 14, carbinol; Triamino-diphenyl-tolylcarbinol |  | C20H21N3O | 詳情 | 供應商 |
| 25834-80-4 | Benzenamine,2,4-bis[(4-aminophenyl)methyl]-; 2,4-Xylidine,a,a'-bis(p-aminophenyl)- (7CI); 2,4-Bis(4-aminobenzyl)aniline; 2,4-Bis(p-aminobenzyl)aniline; 3-(p-Aminobenzyl)-4,4'-diaminodiphenylmethane; a,a'-Bis(p-aminophenyl)-2,4-xylidine |  | C20H21N3 | 詳情 | 供應商 | |
| 113614-46-3 | Isoxazolidine,3-(1H-imidazol-1-ylmethyl)-2-methyl-3,5-diphenyl-, cis- (9CI) |  | C20H21N3O | 詳情 | 供應商 | |
| 20503-88-2 | Piperazine, 1-(4,5-diphenyl-2-oxazolyl)-4-methyl- |  | C20H21N3O | 詳情 | 供應商 | |
| 849925-02-6 | Piperidine,4-[3-(diphenylmethyl)-1,2,4-oxadiazol-5-yl]- |  | C20H21N3O | 詳情 | 供應商 | |
| 27114-26-7 | Quinoline,2-[(4-phenyl-1-piperazinyl)methyl]-, hydrochloride (1:2); Quinoline,2-[(4-phenyl-1-piperazinyl)methyl]-, dihydrochloride (8CI) |  | C20H21N3.2ClH | 詳情 | 供應商 | |
| 122456-37-5 | 1H-Pyrrolo[3,2-c]quinolin-4-amine,2,3-dihydro-N,6-dimethyl-1-(2-methylphenyl)-; MDPQ |  | C20H21N3 | 詳情 | 供應商 | |
| 117992-69-5 | 1H-Isoindole-1,3(2H)-dione,2-[2-[4-(4-chlorophenyl)-1-piperazinyl]ethyl]-, hydrochloride (1:1); 1H-Isoindole-1,3(2H)-dione,2-[2-[4-(4-chlorophenyl)-1-piperazinyl]ethyl]-, monohydrochloride (9CI) |  | C20H21Cl2N3O2 | 詳情 | 供應商 | |
| 117992-68-4 | 1H-Isoindole-1,3(2H)-dione,2-[2-[4-(3-chlorophenyl)-1-piperazinyl]ethyl]-, hydrochloride (1:1); 1H-Isoindole-1,3(2H)-dione,2-[2-[4-(3-chlorophenyl)-1-piperazinyl]ethyl]-, monohydrochloride (9CI) |  | C20H21Cl2N3O2 | 詳情 | 供應商 | |
| 117992-67-3 | 1H-Isoindole-1,3(2H)-dione,2-[2-[4-(2-chlorophenyl)-1-piperazinyl]ethyl]-, hydrochloride (1:1); 1H-Isoindole-1,3(2H)-dione,2-[2-[4-(2-chlorophenyl)-1-piperazinyl]ethyl]-, monohydrochloride (9CI) |  | C20H21Cl2N3O2 | 詳情 | 供應商 | |
| 16869-91-3 | 2,4(1H,3H)-Pyrimidinedione,5-[(2-fluoroethyl)amino]-1,3-bis(phenylmethyl)-, hydrobromide (1:1); 2,4(1H,3H)-Pyrimidinedione,5-[(2-fluoroethyl)amino]-1,3-bis(phenylmethyl)-, monohydrobromide (9CI); Uracil, 1,3-dibenzyl-5-[(2-fluoroethyl)amino]-, monohydrobromide (8CI) |  | C20H21BrFN3O2 | 詳情 | 供應商 | |
| 107680-32-0 | 2,3-Hexanediol,2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (2R,3R)-rel-; 2,3-Hexanediol,2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (R*,R*)-(9CI); 2,3-Hexanediol,2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (R*,R*)-(?à)- |  | C20H21ClFN3O2 | 詳情 | 供應商 | |
| 120944-31-2 | 2(3H)-Oxazolone,4-(4-chlorophenyl)-5-[(4-phenyl-1-piperazinyl)methyl]-, hydrochloride (1:1); 2(3H)-Oxazolone,4-(4-chlorophenyl)-5-[(4-phenyl-1-piperazinyl)methyl]-, monohydrochloride (9CI) |  | C20H21Cl2N3O2 | 詳情 | 供應商 | |
| 104286-55-7 | 3-Quinolinemethanamine,7-chloro-4-[(4-chlorophenyl)amino]-N,N-diethyl- |  | C20H21Cl2N3 | 詳情 | 供應商 | |
| 155020-42-1 | 4-Quinolinamine,7-chloro-N-[3-[(diethylamino)methyl]-4-fluorophenyl]-; 4’-dehydroxy-4’-fluoroamodiaquine |  | C20H21ClFN3 | 詳情 | 供應商 | |
| 118449-23-3 | 4(3H)-Quinazolinone,7-chloro-3-(3-chloro-2-methylphenyl)-2-[[3-(dimethylamino)propyl]thio]- |  | C20H21Cl2N3OS | 詳情 | 供應商 | |
| 151213-15-9 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyr; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-; 8-Desmethoxy-8-fluoro Moxifloxacin |  | C20H21F2N3O3 | 詳情 | 供應商 | |